Login

Zanidip 10mg and 20mg Tablets

*
Pharmacy Only: Prescription

  • Company:

    Recordati Ireland Limited

  • Status:

    No Recent Update

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)

  • Active Ingredient(s):

    Lercanidipine Hydrochloride

    *Additional information is available within the SPC or upon request to the company

Updated on 02 July 2021

File name

zanidip-pl-ie-clean.pdf

Reasons for updating

  • Change to section 3 - how to take/use
  • Change to section 6 - what the product looks like and pack contents

Free text change information supplied by the pharmaceutical company

Information on sodium content added and minor editorial updates.

Updated on 29 November 2019

File name

ie-pl-zanidip-10mg-20mg.pdf

Reasons for updating

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children and adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 3 - use in children/adolescents
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects

Updated on 11 August 2017

File name

PIL_8318_955.pdf

Reasons for updating

  • New PIL for new product

Updated on 11 August 2017

Reasons for updating

  • Change to Section 1 - what the product is
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children and adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 2 - excipient warnings
  • Change to section 3 - dose and frequency
  • Change to section 3 - use in children/adolescents
  • Change to section 3 - how to take/use
  • Change to section 3 - duration of treatment
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 5 - how to store or dispose
  • Change to section 6 - what the product contains
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 01 March 2011

Reasons for updating

  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to instructions about missed dose
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about driving or using machinery
  • Change to MA holder contact details
  • Change to improve clarity and readability
  • Change of special precautions for disposal

Updated on 18 September 2007

Reasons for updating

  • Change to marketing authorisation holder

Updated on 07 March 2006

Reasons for updating

  • Introduction of new strength

Updated on 18 August 2004

Reasons for updating

  • New PIL for medicines.ie